Atlas Trials

Therapeutic Plasma Exchange as an Adjunctive Strategy to Treat Coagulopathy and Inflammation in Severe Covid-19

Clinical trial NCT04613986 · UNKNOWN

Trial details

NCT number
NCT04613986
Sponsor
University of Zurich
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Severe Covid-19
Start date
2021-06-01
Primary completion
2021-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.